Skip to content

The impact of timed protein supplementation to maximize the skeletal muscle adaptive response to resistance type exercise training in healthy young men

The impact of timed protein supplementation to maximize the skeletal muscle adaptive response to resistance type exercise training in healthy young men - Resistance training in young men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38107
Enrollment
44
Registered
2011-09-26
Start date
2011-11-07
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spierfysiologie muscle physiology

Interventions

The intervention period will consist of a 12 week resistance type exercise training program. The training will be performed 3 times per week (Monday, Wednesday en Friday). Every training will last

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy Male Age between 18 and 30 years BMI between 18.5 and 30 kg/m2 Recreationally active, performing sports on a non-competitive basis between 2 and 5 hours p/wk Participants willing and able to give written informed consent and to understand, to participate and to comply with the biomedical research project requirements.

Exclusion criteria

Exclusion criteria: HbA1C level above 6.5% Fasted blood glucose level above 7 mmol/L Serum creatinine level beneath 60 or above 120 µmol/L Participants with a recent history or current state of COPD Participants with a recent history or current state of rheumatoid arthritis Participants with a recent history or current state of musculoskeletal/orthopedic disorders Participants with a recent history or current state of renal disorder Participants with a recent history or current state of cognitive impairment Participants with orthopedic metal implants in the spine and/or upper/lower extremities Participants with lactose intolerance and/or dairy protein allergy Participants who are enrolled in an interventional biomedical research project or have received an investigational new drug or product with the last 30 days prior to screening. Participants who are using anticoagulants

Design outcomes

Primary

MeasureTime frame
Skeletal muscle fiber size

Secondary

MeasureTime frame
Muscle fiber type-specific satellite cell content Quadriceps cross-sectional area Whole body en regional body composition Muscle fiber type-specific myonuclear content Muscle fiber type distribution Muscle strength

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)